BMO Capital Remains a Buy on Ventas (VTR)
BMO Capital analyst Juan C. Sanabria reiterated a Buy rating on Ventas today and set a price target of $100.00.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
C. Sanabria covers the Real Estate sector, focusing on stocks such as Healthpeak Properties, Welltower, and National Health Investors. According to TipRanks, C. Sanabria has an average return of 4.3% and a 56.43% success rate on recommended stocks.
Ventas has an analyst consensus of Strong Buy, with a price target consensus of $97.69.
Based on Ventas’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.66 billion and a net profit of $55.91 million. In comparison, last year the company earned a revenue of $1.36 billion and had a net profit of $46.87 million
Based on the recent corporate insider activity of 104 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of VTR in relation to earlier this year. Last month, Michael Embler, a Director at VTR bought 2,500.00 shares for a total of $197,025.00.
Read More on VTR:
